Position in ICLR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,406,752
+$762,456 QoQ
Shares Held
13,855
-6.8% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#160
of 422 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $179,401,377 across 25 Diagnostics & Research names. ICLR ranks #12 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
109,972 | $55,135,561 | |
| 2 | DHR |
Danaher Corp /De/
|
139,533 | $26,578,245 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
117,365 | $22,677,265 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
22,840 | $12,023,889 | |
| 5 | LH |
Labcorp Holdings Inc.
|
32,320 | $9,049,600 | |
| 6 | DGX |
Quest Diagnostics Inc
|
39,616 | $8,396,611 | |
| 7 | NTRA |
Natera, Inc.
|
27,675 | $7,512,378 | |
| 8 | A |
Agilent Technologies, Inc.
|
48,741 | $6,474,267 |
All Filings in ICLR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,406,752 | 13,855 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,644,296 | 14,859 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,302,896 | 12,638 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,731,400 | 15,608 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,031,791 | 13,969 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,682,839 | 21,046 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,519,567 | 26,320 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,158,742 | 28,397 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,873,395 | 28,307 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $9,262,813 | 27,572 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $1,378,833 | 4,871 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,157,375 | 4,700 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,270,265 | 5,077 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,364,626 | 6,389 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,081,584 | 5,568 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $375,278 | 2,042 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $332,201 | 1,533 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $383,071 | 1,575 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $458,975 | 1,482 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $260,185 | 993 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $238,129 | 1,152 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $336,535 | 1,726 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||